Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: Stocks sink on Evergrande contagion fears

Mon, 20th Sep 2021 12:16

(Alliance News) - Stock prices in London were sharply lower at midday on Monday due to concern about the knock-on effects from the potential debt-fuelled collapse of Chinese real estate firm Evergrande, sending miners and other China-exposed firms lower.

The FTSE 100 index was down 120.36 points, or 1.7%, at 6,843.28 - its lowest level since mid-July. The mid-cap FTSE 250 index was down 345.90 points, 1.5%, at 23,313.04. The AIM All-Share index was down 19.34 points, 1.5%, at 1,256.10.

The Cboe UK 100 index was down 1.4% at 680.40. The Cboe 250 was down 1.2%, at 21,098.30. The Cboe Small Companies was 1.6% lower at 15,299.69.

In mainland Europe, the CAC 40 stock index in Paris was down 2.2% and the newly expanded DAX 40 index in Frankfurt was down 2.1%.

In Asia, the Hang Seng index in Hong Kong ended down 3.3%. Financial markets in Japan were closed on Monday for the Respect for the Aged Day holiday, while in Shanghai, the stock market was closed for the Mid-Autumn Festival.

The Hong Kong stock exchange tumbled on Monday, as Evergrande Property Services Group struggles under a mountain of debt.

The firm, one of the country's biggest property developers, warned it may not be able to repay loans and interest on its bonds - totalling more than USD300 billion - and could go under. With some payments due Monday and Thursday, investors are keeping a nervous eye on the crisis, which has fanned fears of a domestic and international contagion.

Evergrande shares closed down 11% in Hong Kong, while the wider Hang Seng index lost 3.3%.

US stock market futures were set to open sharply lower, extending Friday's losses on concerns over China's indebted property sector and ahead of the Federal Reserve's interest rate decision on Wednesday.

The Dow Jones Industrial Average was called down 1.2%, the S&P 500 down 1.0%, and the Nasdaq Composite down 1.1%.

"Markets in Europe dropped significantly on Monday as the 'risk-off' trading stance prevails ahead of another busy week on the macro front. Investors already had a lot to digest recently, the debt crisis in both of the world's two biggest economies (Evergrande & US debt ceiling) combined with uncertainties about the Federal Reserve's decision this week about the timeline for any tapering are denting market sentiment," said analysts at ActivTrades.

The US Fed starts its two-day policy meeting on Tuesday, with an announcement on Wednesday. Also issuing policy decisions this week are the Bank of Japan and Bank of England.

In the FTSE 100, Prudential was the worst performer, down 8.5%. The life insurer on Sunday said it plans to raise up to around USD2.89 billion on the Hong Kong Stock Exchange.

Prudential is planning a share offer of up to 5% of its issued share capital, or around 130.8 million shares, at a price of no more than HKD172 each, equivalent to around USD22.09.

The offer will consist of an international share placing and a public offer available only to residents of Hong Kong, both at the same price. The public portion will be for up to 32.7 million of the total shares on offer.

Prudential said it wants to increase its Asian shareholder base and the liquidity of its shares in Hong Kong.

The 173-year old insurer last week completed the spinoff of US arm Jackson Financial and declared a demerger dividend. The company still owns 20% of Jackson, and plans to cut its stake to less than 10% over the next 12 months.

"Prudential is closing the book on a messy chapter, with the breakup of the American and Asian businesses now complete, it's looking to make the most of opportunities in Asia. The addressable market here is huge, so coming to the market cap-in-hand does make sense. The scale of the amount needed might be a bit disappointing, but it also adds risk. When you've asked for money, the reaction will be harsh if things don't go to plan," said Hargreaves Lansdown analyst Sophie Lund-Yates.

China-exposed bank and luxury goods maker Standard Chartered and Burberry were down 5.1% and 4.0% respectively.

Anglo American was down 9.1% after Barclays downgraded the miner to Equal Weight from Overweight.

Miners were lower across the board amid wider sector concerns, linked to China. Glencore, BHP and Rio Tinto were down 5.9%, 5.0% and 5.1% respectively.

AJ Bell's Russ Mould said the Evergrande situation is "particularly bad news for miners.

"Any downturn in China would have significant implications for commodities demand given its status as the world's largest consumer of many minerals and metals. The situation also has uncomfortable echoes of 2015 when fears about Chinese debt prompted a big and broad-based market correction."

Elsewhere, AstraZeneca was up 3.1%. The Anglo-Swedish drugmaker said its Enhertu breast cancer drug reduces risk of progression or death by 72% compared to existing treatment trastuzumab emtansine.

Noting "detailed positive results" from its Destiny-Breast03 Phase 3 trial, the company said new tests affirmed the safety and effectiveness of Enhertu. Patients treated with the new drug showed a "strong trend towards improved overall survival", AstraZeneca said.

International Consolidated Airlines Group was up 1.8%. The British Airways owner denied predictions that it will follow in easyJet's footsteps in raising money from shareholders, the Sunday Times reported.

Earlier this month, easyJet tapped investors for GBP1.2 billion in a fully underwritten rights issue to help bolster its balance sheet, as the travel sector continues to be hurt by the pandemic restrictions. Analysts at Goodbody and HSBC said they believed the IAG would follow.

But IAG Chief Executive Officer Luis Gallego denied any plans for a fundraise, telling the Sunday Times: "We do not see the necessity to do a rights issue and are not considering it."

SSE was up 0.1% after it noted a report in the Telegraph that said the energy firm was close to being split into two separate blue-chip companies, following pressure from US activist investor Elliott Management.

Elliott has been in talks with SSE's board to split the company's legacy wholesale networks business from its growing renewable energy operations for more than a year, according to the Telegraph, citing sources close to the situation.

In response, SSE said "there has been no decision to break up" the company. SSE remains fully focused on strategic choices which will "drive shareholder value from the wealth of net zero opportunities", it insisted. SSE said its strategic focus was on renewables and regulated electricity networks, supported by "carefully chosen" businesses.

London's spate of stock market listings looks set to continue. The owner of the Yo! Sushi chain of casual dining restaurants will present to City analysts this week, in preparation for an initial public offering in London as soon as mid-October, Sky News reported on Sunday.

The listing of Snowfox Group is being led by investment bankers at Numis, Sky said, and could give the company a market value of more than GBP750 million. The company also owns the Snowfox and Bento sushi chains in the US and Canada, and the Taiko brand of packaged sushi.

In addition, Eurowag on Monday confirmed plans to list on the London Main Market.

Founded in the Czech Republic in 1995 by Chief Executive Martin Vohanka, Eurowag processes toll and fuel payments for trucks around the continent.

The initial public offering is expected to comprise new shares issued by the company, raising gross proceeds of around EUR200 million to support its growth strategy, as well as the sale of existing shares.

The pound was quoted at USD1.3693 at midday on Monday, down sharply from USD1.3752 at the London equities close Friday.

The euro was priced at USD1.1714, down from USD1.1734. Against the Japanese yen, the dollar was trading at JPY109.58, down from JPY109.92.

Brent oil was quoted at USD73.91 a barrel Monday at midday, down sharply from USD75.06 late Friday. Gold stood at USD1,759.46 an ounce, slightly higher from USD1,754.70.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.